Profound Medical Corp
TSX:PRN
Profound Medical Corp
TSX:PRN
Price:
11.39 CAD
9%
Market Closed
Updated:
May 15, 2024
Profound Medical Corp
Research & Development
|
Profound Medical Corp
Research & Development Peer Comparison
Comparables:
NVCN
OPS
NSCI
TLT
MIR
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Profound Medical Corp
TSX:PRN
|
Research & Development
-$14.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Neovasc Inc
TSX:NVCN
|
Research & Development
-$17.2m
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-16%
|
|
|
Opsens Inc
TSX:OPS
|
Research & Development
-CA$11.3m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-20%
|
|
|
Nanalysis Scientific Corp
XTSX:NSCI
|
Research & Development
-CA$1.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Theralase Technologies Inc
XTSX:TLT
|
Research & Development
-CA$2.8m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-19%
|
|
|
MedMira Inc
XTSX:MIR
|
Research & Development
-CA$352.3k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
See Also
What is Profound Medical Corp's Research & Development?
Research & Development
-14.4m
USD
-14.4m
USD
Based on the financial report for Dec 31, 2023, Profound Medical Corp's Research & Development amounts to -14.4m USD.
What is Profound Medical Corp's Research & Development growth rate?
Research & Development CAGR 5Y
-13%
-13%
Over the last year, the Research & Development growth was 2%.
You don't have any saved screeners yet
